Clinical Trial Update: Safety and Efficacy of L-NAME and Midodrine to Increase MAP [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of L-NAME and midodrine to increase mean arterial pressure in patients with orthostatic hypotension. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Orthostatic Hypotension
• Spinal Cord Injury

Drugs mentioned

• L-NAME (Nω-nitro-L-arginine methyl ester)
• Midodrine (Midodrine)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Orthostatic Hypotension, Spinal Cord Injury | Phase 2 | Status: COMPLETED | Results posted: 2014-04-23